Drugs / SPK-843
SPK-843
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01125644 | May 2010 → Oct 2011 | fungal infectious disease | Proaparts srl | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPK-843 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01125644 ↗ |
| Known as | AMCIPATRICIN DIASCORBATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1616008 ↗ |
| Known as | SPA-843 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1616008 ↗ |
| Known as | SPA-S-843 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1616008 ↗ |
| Modality | Small molecule | — CHEMBL1616008 ↗ |
| Route | Intravenous | “will be administered i.v.” NCT01125644 ↗ |